Latest News and Press Releases

LONDON, Jan. 05, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”) received a Warning Letter dated December 29, 2015, from the United States Food and Drug...

LONDON, Dec. 9, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company") today announced the appointment of Berenberg as Corporate Broker to the Company with...

LONDON, Nov. 23, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company") today announced that it will provide a webcast of the presentations at its investor and...

LONDON, Nov. 20, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company") today announced it will participate in the following conferences. André-Michel...

LONDON, Nov. 17, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company"), a leading global medical technology company, today announced that Rosario Bifulco, a...

LONDON, Nov. 12, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company"), a global medical technology company formed by the merger of Sorin S.p.A ("Sorin"), a...

LONDON, Oct. 29, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company") today announced that the Company will report sales results for the period ended September...

LONDON, Oct. 19, 2015 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) ("LivaNova" or the "Company") today announces the successful completion of the cross-border merger of Sorin S.p.A. and...

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR A PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL CONSTITUTE AN OFFERING OF THE SHARES OF LIVANOVA PLC. ANY...